Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001759138-26-000013
Filing Date
2026-03-23
Accepted
2026-03-23 07:42:34
Documents
13
Effectiveness Date
2026-03-23

Document Format Files

Seq Description Document Type Size
1 S-8 caba-20260323.htm S-8 160881
2 EX-5.1 caba-ex5_1.htm EX-5.1 13583
3 EX-23.1 caba-ex23_1.htm EX-23.1 4445
4 EX-FILING FEES caba_exfilingfees.htm   iXBRL EX-FILING FEES 112854
  Complete submission text file 0001759138-26-000013.txt   442228

Data Files

Seq Description Document Type Size
16 EXTRACTED XBRL INSTANCE DOCUMENT caba_exfilingfees_htm.xml XML 16282
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-294514 | Film No.: 26779914
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)